UC's Siemens Simulation Technology Center participates in national conference
University of Cincinnati visiting assistant professor Gil Jun Lee, Ph.D., attended the American Society of Engineering Education's conference for industry and education in New Orleans.
He was joined by Dora Smith and Gil Morris from Siemens PLM team. This conference was organized by various divisions that work to collaborate academic, industry and government programs and partnerships.
Lee presented the poster of the simulation center at the conference highlighting the role of the simulation center in integrating Siemens PLM software’s in Academic curriculum at UC.
The poster detailed how various Siemens PLM software’s are integrated into coursework starting from freshmen year till senior year and graduate level courses. Along with course work, Siemens PLM software’s are also used for research work and we are also developing apps for additive manufacturing.
This new approach of teaching is helping students get co-ops and connect to the industry where simulation software is used extensively. The new graduate engineers are better prepared to attack real-world problems in industry.
Learn more about the poster and abstract.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
Telescope captures information about lonely Jupiter-like gas giant
May 13, 2026
Science outlets highlight a University of Cincinnati student's collaborative discoveries about an exoplanet 901 light years away.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.